SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 Jul 24, 2024–Jul 28, 2024 Nangang District Taiwan
News Nov 06, 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News Mar 26, 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News Nov 06, 2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Oct 18, 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Webinar Navigating the Tracks: Opportunities in the Korean Railway Industry Dec 12, 2023 09:00–10:15 Switzerland
Analysis Mar 22, 2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Recordings Jun 19, 2023 MARKET RAILWAYS TRENDS IN TÜRKIYE This webinar provided an insight into the development of railways in Türkiye. At the crossroads of Europe, the Middle East and Asia, Türkiye has ...
News Jan 26, 2023 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...
News Nov 23, 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News May 26, 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Global Opportunities Oct 28, 2022 Pakistan: market snapshot infrastructure With a population of over 230 million, Pakistan has massive potential as a growing market and a huge need in the upgrade of the infrastructure. O...